Back to Results
First PageMeta Content
Immunosuppressants / Macrolides / Drug-eluting stent / Medical equipment / Stent / Bare-metal stent / Restenosis / Zotarolimus / Sirolimus / Medicine / Implants / Interventional cardiology


WEDNESDAY, NOVEMBER 9, VOL. 15, NO. 215 TCT 2011
Add to Reading List

Document Date: 2011-11-15 09:33:57

Open Document

File Size: 180,30 KB

Share Result on Facebook

City

Dublin / New York / Auckland / /

Company

Biosensia / Medical Device Daily Washington / Svelte Medical Systems / Medtronic / ACT Venture Capital / 10 Svelte Medical Systems / /

Continent

Europe / /

Country

New Zealand / United States / Ireland / /

Currency

USD / EUR / /

/

Event

Person Communication and Meetings / Funding / FDA Phase / Reorganization / /

Facility

Atlantic Bridge / Auckland City Hospital / /

IndustryTerm

comparative devices / bare-metal stent control / bare metal stent version / bio-erodable drug carrier / access site / nonthrombogenic drug carrier / balloon control band technology / start-up / drug carrier / ancillary products / care solutions / /

MedicalCondition

stent thrombosis / both coronary artery disease / diabetes / coronary artery disease / /

MedicalTreatment

drug carrier / balloon catheter / stent implantation / /

Organization

Cardiovascular Research Foundation / Japan’s Pharmaceuticals and Medical Devices Agency / Pharmaceuticals and Medical Devices Agency / Auckland City Hospital / FDA / /

Person

AMANDA PEDERSEN / Mark Pomeranz / Omar Ford / Mark Webster / /

/

Position

Daily Staff Writer / Editor / interventional cardiologist / Staff Writer / president/CEO / principal investigator for the DIRECT study / /

Product

All / Series B / Resolute drug-eluting stent / All-In-One drug / Biosensia / Resolute / /

ProvinceOrState

New Jersey / /

Technology

balloon control band technology / /

URL

www.medicaldevicedaily.com / /

SocialTag